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Abstract
Fanconi anemia (FA) is a rare recessive disease, characterized by congenital defects, bone marrow failure, and
increased cancer susceptibility. FA is caused by biallelic mutation of any one of sixteen genes. The protein products
of these genes function cooperatively in the FA-BRCA pathway to repair DNA interstrand crosslinks (ICLs). A central
step in the activation of this pathway is the monoubiquitination of the FANCD2 and FANCI proteins.
Monoubiquitinated FANCD2 and FANCI localize to discrete chromatin regions where they function in ICL repair.
Despite their critical role in ICL repair, very little is known about the structure, function, and regulation of the FANCD2
and FANCI proteins, or how they are targeted to the nucleus and chromatin. In this study, we describe the functional
characterization of an amino-terminal FANCD2 nuclear localization signal (NLS). We demonstrate that the amino
terminal 58 amino acids of FANCD2 can promote the nuclear expression of GFP and is necessary for the nuclear
localization of FANCD2. Importantly, mutation of this FANCD2 NLS reveals that intact FANCD2 is required for the
nuclear localization of a subset of FANCI. In addition, the NLS is necessary for the efficient monoubiquitination of
FANCD2 and FANCI and, consequently, for their localization to chromatin. As a result, FANCD2 NLS mutants fail to
rescue the ICL sensitivity of FA-D2 patient cells. Our studies yield important insight into the domain structure of the
poorly characterized FANCD2 protein, and reveal a previously unknown mechanism for the coordinate nuclear import
of a subset of FANCD2 and FANCI, a key early step in the cellular ICL response.
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Introduction
Fanconi anemia (FA) is a rare autosomal and X-linked
recessive disease, characterized by congenital abnormalities,
pediatric bone marrow failure, and heightened cancer
susceptibility [1]. FA is caused by biallelic mutations in any one
of 16 genes (FANCA, -B, -C, -D1/BRCA2, -D2, -E, -F, -G, -I, -J/
BRIP1, -L, -M, -N/PALB2, -P/SLX4, -O/RAD51C, -Q/ERCC4)
[2-4]. The protein products of these genes function
cooperatively in the FA-BRCA pathway to repair DNA
interstrand crosslinks (ICLs) and to maintain chromosome
stability. A central step in the activation of the FA-BRCA
pathway is the monoubiquitination of the FANCD2 and FANCI
proteins. Monoubiquitination of FANCD2 and FANCI is
catalyzed by the FA core complex, which is comprised of
FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL,
and FANCM, in addition to the E2 ubiquitin conjugating enzyme
UBE2T, as well as FAAP100, FAAP24, and FAAP20 [4,5].
Following monoubiquitination, FANCD2 and FANCI co-localize
in discrete nuclear foci with several well characterized DNA
repair proteins including BRCA1 and NBS1 [6-9]. However,
importantly, the domain structure, regulation, and function of
both FANCD2 and FANCI are poorly described. Furthermore,
the mechanism(s) by which FANCD2 and FANCI are localized
to the nucleus remains unknown.
Several studies have established that the FANCD2 and
FANCI proteins function proximal to or within chromatin
[6,8-10]. As FANCD2 and FANCI are relatively large proteins,
with molecular weights of 164 and 149 kDa, respectively, the
nuclear import of these proteins necessitates an energy-
dependent active transport mechanism. The most common
nuclear protein transport mechanism involves the recognition of
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nuclear localization signals (NLSs) by members of the importin
(Imp) superfamily of nuclear transporters, followed by
translocation through the nuclear pore complexes [11]. NLSs
generally comprise short stretches of basic amino acids either
alone (monopartite) or separated by one (bipartite) or two
(tripartite) mutation-tolerant linker regions of 10-12 amino
acids. NLSs in the cargo protein are recognized by the Imp α
subunit of the Imp α/β heterodimer or by Imp β alone, and
nuclear transport is coupled to GTP hydrolysis [11].
In this study, we describe the identification and functional
characterization of a NLS in the amino terminus of FANCD2.
We demonstrate that the amino terminal 58 amino acids of
FANCD2 can promote the nuclear expression of green
fluorescent protein (GFP). In addition, using deletion and site-
directed mutagenesis strategies we establish that the amino
terminal 58 amino acids of FANCD2 are necessary for the
nuclear and chromatin localization of FANCD2 in FA-D2
patient-derived cells. Importantly, we also demonstrate that the
nuclear and chromatin localization of a subset of the cellular
pool of FANCI is dependent on the nuclear import of FANCD2.
Moreover, the FANCD2 NLS is required for the efficient DNA
damage-inducible monoubiquitination of FANCD2 and FANCI.
Consequently, the FANCD2 NLS mutants fail to rescue the ICL
hypersensitivity of FA-D2 patient-derived cells. Our results
suggest that a subset of FANCI is translocated to the nucleus
in a piggyback mechanism with FANCD2, dependent on its
amino-terminal NLS, and suggest that FANCD2 and FANCI are
targeted to the nucleus as a heterodimer. These findings lend
important insight into the structure and regulation of two poorly
characterized tumor suppressor proteins with key early roles in
the cellular ICL response.
Results
FANCD2 contains a highly conserved amino-terminal
nuclear localization signal, which facilitates nuclear
expression of GFP
In silico analysis using cNLS mapper uncovered several
high-scoring Imp α/β-dependent bipartite NLSs within the
amino-terminal 58 amino acids of FANCD2 (Figs. S1A and B)
[12]. In contrast, cNLS mapper did not predict any high scoring
NLSs in FANCI. A sequence alignment of FANCD2 from
multiple species illustrates strong evolutionary conservation in
general (Fig. S1C). However, in contrast to the sequence
divergent carboxy-terminus, the alignment illustrates strong
conservation of several blocks of basic amino acids within the
amino terminal 58 amino acids (Figs. 1A and S1C). To
determine if this entire region or amino acids 1-27 or 24-55 -
the two highest scoring predicted NLSs (Fig. S1B) - were
sufficient for nuclear localization, we fused amino acids 1-58
(D2-1-58-GFP), 1-27 (D2-1-27-GFP), or 24-55 (D2-24-55-GFP)
of FANCD2 to the amino terminus of GFP (Fig. 1B). HeLa cells
were transiently transfected with wild type GFP (GFP-WT) and
the FANCD2-GFP fusion constructs and cells were analyzed
by inverted fluorescence microscopy. HeLa cells transiently
expressing GFP-WT, D2-1-27-GFP, or D2-24-55-GFP all
exhibited uniform cytoplasmic and nuclear fluorescence (Fig.
1B). Conversely, cells transiently expressing D2-1-58-GFP
primarily exhibited nuclear fluorescence (Fig. 1B). Similar
findings were observed with IMR90 cells (Fig. S1D). These
results demonstrate that the amino terminal 58 amino acids of
FANCD2 are necessary to promote exclusive nuclear GFP
localization. In support of an importin α/β-dependent
mechanism of nuclear import, treatment with ivermectin, a
broad-spectrum inhibitor of importin α/β-dependent nuclear
import [13], inhibited the exclusive nuclear localization of
D2-1-58-GFP, herein referred to as D2-NLS-GFP (Figs. S1E
and F). In addition, mass spectrometry analysis of FANCD2
immune complexes revealed the presence of importin β1, as
well as the nuclear pore complex proteins NUP160 and
NUP155 (Table S1). Using a chromatin fractionation approach
we also observed that the majority of GFP-WT resided in a
soluble cytoplasmic and nuclear fraction (S) (Figure S1G, lane
5). While a large proportion of D2-NLS-GFP also resided in a
soluble cytoplasmic and nuclear fraction, a higher relative
proportion of D2-NLS-GFP was detected in a chromatin-
associated nuclear fraction (C) (Figures S1G, lane 9 and H).
Taken together these results demonstrate that the amino-
terminal 58 amino acids of FANCD2 harbor a bona fide NLS
that can promote exclusive nuclear GFP localization.
The FANCD2 NLS is required for the nuclear
localization of FANCD2
To determine the functional significance of the FANCD2
NLS, we next generated deletion and missense mutations of
this amino acid sequence. Two amino-terminal deletion
mutations, FANCD2-ΔN57, lacking amino acids 2-58, and
FANCD2-ΔN100, lacking amino acids 2-101, were generated
(Figure 2A). In addition, using a site-directed mutagenesis
approach, amino acids K4, R5, and R6, the most highly
conserved basic amino acids within this region (Figure 1A),
were mutated to N4, N5, and N6, herein referred to as
FANCD2-3N (Figure 2A). These FANCD2 cDNAs were cloned
into the pLenti6.2 lentiviral vector, which contains a carboxy-
terminal V5 tag, and lentivirus was used to generate a series of
PD20 FA-D2 patient-derived cells stably expressing wild type
or mutant FANCD2. These FA-D2 cells harbor a maternally
inherited A-G change at nucleotide 376 that leads to the
production of a severely truncated protein, and a paternally
inherited missense hypomorphic mutation leading to a R1236H
change [14]. Immunofluorescence microscopy (IF) revealed
that deletion of the FANCD2 NLS resulted in exclusive
cytoplasmic localization of FANCD2, in contrast to wild type
FANCD2, which exhibited both diffuse and focal nuclear
localization (Figures 2B and C). Furthermore, permeabilization
of FA-D2 cells expressing the FANCD2-ΔN57 mutant with non-
ionic detergent resulted in complete loss of fluorescent signal
indicating the high solubility of cytoplasmic FANCD2-ΔN57
(Figure 2B). In contrast, nuclear and focal localization of wild
type FANCD2 was largely resistant to permeabilization (Figure
2B). Similar findings were obtained with FA-D2 cells
expressing FANCD2-ΔN100 (Figure 2C). In addition, a partial
yet significant defect in nuclear localization was observed for
the FANCD2-3N mutant, compared to wild type FANCD2
(Figure 2C).
Characterization of a FANCD2 NLS
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The FANCD2 NLS is required for the nuclear
localization of a subset of FANCI
Next, we examined the sub-cellular localization of FANCI in
our FA-D2 cell series. It is important to note that the FA-D2
cells used in this study, like all known FA-D2 patient-derived
lines, harbor hypomorphic FANCD2 mutations and express
residual FANCD2 protein [15]. IF analysis revealed that FANCI
was uniformly present in both the cytoplasm and nucleus of
FA-D2 cells in the absence or presence of MMC (Figures 3A
and B). Importantly, complementation of FA-D2 cells with wild
type FANCD2 (FANCD2-WT) led to a large increase in
exclusive nuclear localization of FANCI (Figures 3A and B).
Furthermore, MMC-inducible FANCI nuclear foci formation was
restored in these cells, consistent with previous studies [8,9]
(Figure 3A). Similar results were obtained with hTERT-
immortalized mutant and FANCD2-complemented KEAE FA-
D2 patient-derived cells [15] (Figure S2A). In contrast to wild
type FANCD2, both the FANCD2-ΔN57 and -ΔN100 NLS
mutants failed to promote the exclusive nuclear localization of
FANCI (Figures 3B and S2B). Furthermore, a partial defect in
FANCI nuclear localization was observed for FA-D2 cells
expressing FANCD2-3N (Figure 3B). To rule out the possibility
that deletion of the amino-terminus of FANCD2 prevented its
heterodimerization with FANCI, we tested the ability of the
FANCD2-ΔN57 mutant to physically interact with FANCI by
transiently transfecting COS-7 cells with GFP-tagged FANCI
and V5-tagged FANCD2-WT or FANCD2-ΔN57 and examining
their ability to interact by co-immunoprecipitation. Co-
expression of both FANCD2-WT and FANCD2-ΔN57 with
FANCI led to its stabilization (Figure 3C, upper panel, lanes 3
and 4). Furthermore, the FANCD2-ΔN57 mutant was capable
of interacting with FANCI and, when corrected for levels of
protein input, no appreciable difference in the level of
interaction between FANCI and FANCD2-ΔN57 and FANCI
and FANCD2-WT was observed (Figure 3C, lower panels,
lanes 3 and 4). Together, these results establish that the
nuclear localization of a subset of FANCI is dependent in part
on FANCD2, and suggest a piggyback mechanism of nuclear
FANCI targeting that is dependent on the FANCD2 amino-
terminal NLS.
Figure 1.  The amino terminal 58 amino acids of FANCD2 contain a highly conserved nuclear localization signal, which
facilitates nuclear expression of GFP.  (A) A Clustal Omega multiple sequence alignment of the amino terminus of FANCD2
demonstrates strong evolutionary conservation of several blocks of basic amino acids of this region, indicated by blue bars. The red
box indicates the highly conserved K4, R5, and R6 residues selected for mutagenesis. (B) The amino terminal 58 amino acids of
FANCD2 are required to promote exclusive nuclear expression of GFP. HeLa cells were transiently transfected with wild type GFP
(GFP-WT), amino acids 1-27 (D2-1-27-GFP), 24-55 (D2-24-55-GFP), or 1-58 (D2-1-58-GFP) of FANCD2 fused to GFP followed by
analysis by inverted fluorescence microscopy.
doi: 10.1371/journal.pone.0081387.g001
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The FANCD2 NLS is required for efficient FANCD2 and
FANCI monoubiquitination and chromatin association
Next, we examined the consequences of disruption of the
FANCD2 NLS on the monoubiquitination and chromatin
localization of FANCD2 and FANCI. Similar to the FANCD2-
K561R mutant that cannot be monoubiquitinated [6], mutation
of the FANCD2 NLS had a significant impact on its
monoubiquitination: the ΔN57 and ΔN100 NLS deletion
mutants failed to undergo spontaneous or MMC-inducible
FANCD2 monoubiquitination (Figure 4A, lanes 7-10). A faint
band of similar molecular weight to wild type FANCD2 can be
seen in the α-FANCD2 panel for FA-D2 cells expressing
FANCD2-ΔN57 and -ΔN100 (Figure 4A, lanes 7-10). This is
most likely the hypomorphic FANCD2-R1236H missense
mutant (see Materials and Methods) [14], as this band is also
present in FA-D2 cells expressing LacZ (lanes 1 and 2) and is
Figure 2.  The FANCD2 NLS is required for the nuclear localization of FANCD2.  (A) Schematic diagram of the FANCD2
constructs generated in this study. In addition to the NLS, FANCD2 harbors a CUE (for coupling of ubiquitin conjugation to
endoplasmic reticulum degradation) ubiquitin-binding domain [47], a PCNA-interaction motif or PIP-box [19], and a carboxy-terminus
EDGE motif [10]. (B) FA-D2 cells stably expressing FANCD2-WT and FANCD2-∆N57 were incubated in the absence (NT) or
presence of 40 nM MMC for 24 h. Cells were then incubated in the absence (-Pre-Perm) or presence (+Pre-Perm) of pre-
permeablization buffer, fixed, stained with mouse monoclonal anti-V5 antibody (green) and counterstained with DAPI (blue). (C) FA-
D2 cells stably expressing LacZ, FANCD2-WT, FANCD2-∆N57, FANCD2-∆N100, and FANCD2-3N were incubated in the absence
(NT) or presence of MMC for 24 h, fixed, and stained with rabbit polyclonal anti-FANCD2 antibody, and counterstained with
phalloidin and DAPI. At least 300 cells were scored for cytoplasmic (Cyto.), nuclear (Nucl.), and both cytoplasmic and nuclear (Both)
localization of FANCD2.
doi: 10.1371/journal.pone.0081387.g002
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not recognized by the anti-V5 antibody (Figure 4, lanes 7-10).
The FANCD2-3N mutant also exhibited considerably reduced
spontaneous and MMC-inducible monoubiquitination (Figure
4A, lanes 11 and 12). Previous studies have demonstrated
that FANCD2 and FANCI monoubiquitination are
interdependent [8,9]. Accordingly, FANCI monoubiquitination
was largely abrogated in FA-D2 cells stably expressing the
ΔN57 and ΔN100 NLS deletion mutants, similar to that
observed in cells expressing FANCD2-K561R (Figure 4A,
lanes 5-10). A very modest statistically insignificant decrease
in FANCI monoubiquitination was also observed for FA-D2
cells expressing the FANCD2-3N mutant (Figure 4A, lanes 11
and 12). In addition, a chromatin fractionation approach
revealed that the FANCD2-ΔN57, -ΔN100, and -3N mutants
were largely defective in chromatin localization compared to
FANCD2-WT (Figures 4B and C). Furthermore, while robust
FANCI chromatin localization was observed for cells
expressing FANCD2-WT, in comparison, FANCI chromatin
localization was considerably diminished in cells expressing the
FANCD2-ΔN57, -ΔN100, and -3N mutants (Figures 4B and C
and S3). It is important to note that this particular fractionation
protocol does not distinguish between true chromatin and the
nuclear matrix.
Figure 3.  The FANCD2 NLS is required for the nuclear localization of a subset of FANCI.  (A) FA-D2 patient cells or FA-D2
cells stably expressing FANCD2-WT were incubated in the absence (NT) or presence of MMC for 24 h, fixed, stained with rabbit
polyclonal anti-FANCD2 or anti-FANCI antibody and counterstained with phalloidin and DAPI. AF-488, Alexa Fluor 488. (B) FA-D2
cells stably expressing LacZ, FANCD2-WT, FANCD2-∆N57, FANCD2-∆N100, and FANCD2-3N were incubated in the absence (NT)
or presence of MMC for 24 h, fixed, and stained with rabbit polyclonal anti-FANCI antibody, and counterstained with phalloidin and
DAPI. At least 300 cells were scored for cytoplasmic (Cyto.), nuclear (Nucl.), and both cytoplasmic and nuclear (Both) localization of
FANCI. (C) COS-7 cells were transiently transfected with no DNA, FANCI-GFP, FANCI-GFP plus FANCD2-V5-WT, or FANCI-GFP
plus FANCD2-V5-∆N57. Whole-cell lysates were immunoprecipitated with anti-V5 or anti-GFP antibodies and immune complexes
immunoblotted with anti-GFP and anti-V5 antibodies.
doi: 10.1371/journal.pone.0081387.g003
Characterization of a FANCD2 NLS
PLOS ONE | www.plosone.org 5 November 2013 | Volume 8 | Issue 11 | e81387
The FANCD2 NLS mutants fail to correct the ICL
sensitivity of FA-D2 patient cells
FA patient-derived cells are hypersensitive to ICL-induced
cytotoxicity and clastogenicity [16]. Therefore, we next
assessed the ability of the FANCD2 NLS mutants to rescue the
MMC sensitivity of FA-D2 cells. In a MMC clastogenicity assay,
FA-D2 cells expressing the ΔN57 and ΔN100 NLS mutants
exhibited markedly elevated levels of chromosome aberrations,
including gaps and breaks, dicentrics, and radial formations,
compared with FA-D2 cells complemented with wild type
FANCD2 (p = 0.001 and 1.1 x 10-5, respectively for 16 nM
MMC) (Figure 5A). In addition, in a MMC cytotoxicity assay,
similar to FA-D2 cells expressing FANCD2-K561R [6], cells
expressing the FANCD2-ΔN57 and -ΔN100 NLS mutants
displayed increased MMC sensitivity compared with cells
expressing wild type FANCD2 (p < 0.05 at 50 nM for FANCD2-
ΔN57, -ΔN100, and -K561R compared with wild type FANCD2)
(Figure S4). Recent studies have demonstrated increased
error-prone nonhomologous DNA end joining (NHEJ) in FA
patient cells [17]. Therefore, we also examined the recruitment
of DNA-PKCS to nuclear foci in FA-D2 cells expressing LacZ,
wild type FANCD2 or the FANCD2 ΔN57 mutant, using an
antibody raised against DNA-PKCS phosphorylated on S2056, a
marker of NHEJ [17,18]. Persistent increased DNA-PKCS
pS2056 nuclear foci formation was observed in FA-D2 cells
expressing LacZ following treatment with MMC, and this
phenotype was rescued by wild type FANCD2 (Figure 5B). In
contrast, we observed markedly increased MMC-inducible
DNA-PKCS pS2056 nuclear foci formation in FA-D2 cells
expressing FANCD2 ΔN57, compared to cells expressing LacZ
or wild type FANCD2 (Figure 5B). Taken together, these
results demonstrate that the FANCD2 NLS is essential for the
correct function of the FA-BRCA pathway in the cellular ICL
response.
Figure 4.  The FANCD2 NLS is required for efficient FANCD2 and FANCI monoubiquitination and chromatin
association.  (A) FA-D2 cells stably expressing LacZ, FANCD2-WT, FANCD2-K561R, FANCD2-∆N57, FANCD2-∆N100 and
FANCD2-3N were incubated in the absence and presence of 250 nM MMC for 18 h, and whole-cell lysates were immunoblotted
with antibodies to FANCD2, V5, FANCI and α-tubulin. The FANCD2 and FANCI L/S ratios are the ratios of monoubiquitinated to
nonubiquitinated protein, and were calculated by measuring protein band intensities using ImageJ image processing and analysis
software (http://rsb.info.nih.gov/ij/). (B and C) FA-D2 cells stably expressing FANCD2-WT, FANCD2-∆N57, FANCD2-∆N100 and
FANCD2-3N were treated as above and cell pellets were fractionated into soluble (S) and chromatin-associated (C) fractions.
Fractions were immunoblotted with antibodies against V5, FANCI, α-tubulin and H2A. W, unfractionated whole cell extract.
doi: 10.1371/journal.pone.0081387.g004
Characterization of a FANCD2 NLS
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Discussion
Despite their critical role in the cellular ICL response and
their tumor suppressor function, very little is known about the
structure, function, and regulation of the FANCD2 and FANCI
proteins. For FANCD2, a large 1451 amino acid protein, only
two functional motifs, a PCNA-interaction motif, or PIP box, and
a carboxy-terminus EDGE motif, have been described to date
Figure 5.  The FANCD2 NLS mutants fail to correct the ICL
sensitivity of FA-D2 patient cells.  (A) FA-D2 cells stably
expressing LacZ, FANCD2-WT, FANCD2-∆N57, FANCD2-
∆N100, FANCD2-3N, or FANCD2-K561R were incubated in the
absence or presence of 8 or 16 nM MMC for 24 h and the
numbers of chromosome aberrations including gaps and
breaks, dicentrics, and complex chromosome aberrations,
including radial formations, were scored. Metaphase spreads
were analyzed using a Zeiss AxioImager.A1 upright
epifluorescent microscope with AxioVision LE 4.6 image
acquisition software. At least 80 metaphases were scored per
treatment. Error bars represent the standard error of the
means. (B) FA-D2 cells stably expressing LacZ, FANCD2-WT
and FANCD2-∆N57 were incubated in the absence (NT) or
presence of 40 nM MMC for 18 h, and allowed to recover for 0,
4.5 or 7 h. Cells were then fixed, stained with rabbit polyclonal
anti-DNA-PKCS pS2056, and counterstained with DAPI. At least
300 cells were scored for nuclei with > 5 DNA-PKCS foci. Error
bars represent the standard error of the means from two
independent experiments. ***, p < 0.001.
doi: 10.1371/journal.pone.0081387.g005
[10,19]. Our laboratory has also recently identified and
characterized a CUE ubiquitin-binding domain in the amino-
terminus of FANCD2, which mediates noncovalent binding to
ubiquitin, and is essential for efficient cellular ICL repair [20]. In
this study we describe the functional characterization of an
amino terminal FANCD2 NLS. While a previous study reported
the existence of a FANCD2 NLS, this study failed to examine
the functional consequences of its disruption in a FA-D2
patient-derived cell system [21]. Here, we demonstrate that
fusion of amino acids 1-58 of FANCD2 to the amino terminus of
GFP drives its exclusive nuclear localization. cNLS mapper
identified several high scoring putative bipartite NLSs within
this region, in particular, amino acids 2-27 and 24-55. However,
in contrast to amino acids 1-58, fusion of either sequence to
GFP failed to drive exclusive nuclear GFP expression.
Furthermore, mutation of K4, R5, and R6, the most highly
conserved block of basic amino acids within this region,
reduced, but did not abrogate, nuclear FANCD2 localization in
FA-D2 cells. These results establish that the functional NLS
elements are harbored within the amino terminal 58 amino
acids. While the classical bipartite NLS comprises two clusters
of basic amino acids separated by a 10-12 amino acid linker
region, exemplified by the NLS of nucleoplasmin [22,23],
unconventional bipartite NLSs with extended linker lengths
have also been described [24-26]. However, cNLS mapper
searches for both conventional and unconventional bipartite
NLSs and only detected the former [12]. In addition to
monopartite and bipartite NLSs, at least two other classes of
NLS have been described: tripartite containing three clusters of
basic amino acids similar to those found in L-periaxin and the
epidermal growth factor receptor (EGFR) family [27,28], as well
as NLSs containing dispersed basic residues within a random
coil structure such as that found for 5-lipoxygenase [29]. These
NLSs are poorly characterized in comparison with their mono-
and bi-partite counterparts and are not predicted by cNLS
mapper or PSORT II amino acid prediction algorithms. While
the crystal structure of the murine Fanci-Fancd2 heterodimer
(ID2) has been solved, the majority of the NLS described in this
study was not crystallized precluding speculation about the
structure of this region [30]. Protein secondary structure
prediction algorithms indicate that this region is comprised
largely of random coils. It is also important to note that
FANCD2 harbors several putative phosphorylation sites within
the amino terminal 58 amino acids (PhosphoSitePlus), which
may also contribute to the regulation of its nuclear localization
[31].
Our studies suggest that FANCD2 is imported to the nucleus
via an importin α/β-dependent mechanism as treatment with
ivermectin, a broad-spectrum inhibitor of importin α/β-
dependent nuclear import [13], results in markedly decreased
exclusive nuclear localization of D2-NLS-GFP. Furthermore,
using mass spectrometry we have recently detected importin
β1, as well as the nuclear pore complex proteins NUP160 and
NUP155, in FANCD2 immune complexes (Table S1). In
summary, our functional analyses have revealed the following
important points: 1) the NLS is necessary for the nuclear
localization of FANCD2, 2) the FANCD2 NLS is required for the
nuclear localization of a subset of FANCI, 3) the NLS is
Characterization of a FANCD2 NLS
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necessary for the efficient monoubiquitination of both FANCD2
and FANCI, and 4) the NLS is required for the localization of
both FANCD2 and FANCI in chromatin. Consequently, FA-D2
cells expressing FANCD2 NLS deletion mutants are defective
in the repair of ICLs. Our studies provide additional important
insight into the domain structure of FANCD2, and suggest a
novel FANCD2-dependent piggyback mechanism of FANCI
nuclear import. Furthermore, our results suggest that a subset
of FANCD2 and FANCI are targeted to the nucleus as a
heterodimer. These findings lend important insight into the
structure and regulation of two poorly characterized tumor
suppressor proteins with key early roles in the cellular ICL
response.
Here we have established that FANCI is, at least partially,
dependent on FANCD2 for both its nuclear localization and
chromatin association: In FA-D2 patient cells, as well as FA-D2
cells expressing the FANCD2 NLS mutants, FANCI localized
diffusely to the cytoplasm and nucleus. The introduction of wild
type FANCD2 into these cells resulted in a large increase in
exclusively nuclear FANCI as well as its chromatin localization,
particularly following exposure to MMC. In contrast, we, and
others, have observed robust nuclear localization of FANCD2
in FA-I cells, indicating that FANCD2 is not dependent on
FANCI for its nuclear localization [32]. A previous study of the
patient-derived FANCI R1299X nonsense mutant, which lacks
its carboxy-terminal 30 amino acids, demonstrated that FANCI
harbors a monopartite NLS in this region [32]. While loss of this
NLS reduced FANCI nuclear accumulation, this NLS was not
completely necessary for FANCI or FANCD2 nuclear
accumulation, strongly suggesting the existence of alternative
nuclear import mechanisms for both proteins, consistent with
our data [32]. The elucidation of the crystal structure of the ID2
heterodimer indicates that the FANCD2 and FANCI NLSs are
spatially separated within this structure [30], arguing against
the simultaneous contribution of both NLSs to nuclear import of
the ID2 complex. Taken together, these results suggest that
FANCI localizes to the nucleus via FANCD2-independent and -
dependent mechanisms (Figure 6). These findings are also
consistent with the observation that only a minor fraction of the
cellular pools of FANCD2 and FANCI physically interact [8,9],
reinforcing the concept of ID2 complex-independent functions
for both proteins, such as that recently described by Chaudhury
and colleagues [33]. A recent study has also established that a
fraction of FANCD2 is transported to the nucleus following
MMC exposure via an indirect interaction with importin 4
(IPO4), which is mediated by the C/EBPδ transcription factor
[34]. While clearly important for ICL repair, this mechanism in
unlikely to be the major mechanism of FANCD2 nuclear import
as robust levels of nuclear FANCD2 were observed in C/EBPδ-
null mouse embryonic fibroblasts as well as cells depleted of
IPO4 and C/EBPδ [34]. Nevertheless, this C/EBPδ/IPO4-
dependent FANCD2 nuclear import mechanism could account
for the low levels of nuclear FANCD2-ΔN57 and FANCD2-
ΔN57 observed in our studies.
Interestingly, we observed markedly increased MMC-
inducible chromosome aberrations and DNA-PKCS pS2056
nuclear foci formation in FA-D2 cells expressing FANCD2-
ΔN57, compared to FA-D2 cells expressing LacZ. These
results suggest that the FANCD2-ΔN57 mutant may act in a
dominant-negative manner. The FA-D2 patient-derived cells
used in this study are compound heterozygous for FANCD2
mutations (see Materials and Methods). This variant is
Figure 6.  FANCD2-dependent and -independent mechanisms of FANCI nuclear localization.  We propose that a subset of
FANCI (blue) associates with FANCD2 (red) in the cytoplasm, and that the ID2 heterodimer is transported to the nucleus via an
importin α/β (brown)-mediated transport mechanism, using the amino terminal FANCD2 NLS (light green). Nuclear ID2 binds to
DNA (orange) and is also phosphorylated by the ATM/ATR kinases (dark green). One or both of these events may trigger ID2
complex restructuring, facilitating FANCD2 and FANCI monoubiquitination by FANCL (black), UBE2T (yellow) and the FA core
complex (not shown).
doi: 10.1371/journal.pone.0081387.g006
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detectable by immunoblotting (see Figure 4A, top panel) and
is predicted to retain residual or partial function. Indeed, the
vast majority of FA-D2 patient-derived cells retain residual
FANCD2 function with complete loss of FANCD2 predicted to
result in embryonic lethality [15]. Our results suggest that the
FANCD2-ΔN57 mutant interferes with residual FANCD2
R1236H function, perhaps competing with FANCD2 R1236H
for heterodimerization with FANCI, or in a manner analogous to
missense p53 mutations, by assembling into nonfunctional
homo-oligomers, the formation of which has been suggested
by previous studies [30,35].
Based on our findings, and those of several other groups, we
propose the following model for early steps in the FA-BRCA
pathway of ICL repair (Figure 6). A subset of the total cellular
pools of FANCD2 and FANCI associate in the cytoplasm to
assemble into the ID2 heterodimer. The ID2 heterodimer is
transported to the nucleus most likely via an importin α/β-
mediated transport process, using the amino terminal NLS of
FANCD2. Once inside the nucleus the ID2 heterodimer is
targeted to sites of ICL damage possibly via the association of
FANCD2 with PCNA and the replication fork machinery [19].
Recent in vitro studies have demonstrated that FANCI binding
to DNA is necessary for robust stimulation of the
monoubiquitination of FANCD2 [36]. However, analysis of the
ID2 crystal structure indicates that the FANCD2 K561 side
chain, the site of monoubiquitination, is embedded within the
ID2 interface [30]. Furthermore, a solvent accessible tunnel
adjacent to FANCD2 K561 is predicted to be too small to
accommodate the active site of the UBE2T ubiquitin-
conjugating enzyme [30,37]. Therefore, either 1)
monoubiquitination occurs on FANCD2 and FANCI monomers
prior to ID2 heterodimerization or 2) binding of the ID2 complex
to DNA leads to a conformational change in the ID2 structure
leading to the exposure of K561R and FANCI K523, and their
subsequent monoubiquitination, as has been proposed [36]. A
recent study by Sareen and colleagues suggests that activation
of the FA-BRCA pathway coincides with dissociation of
FANCD2 and FANCI [38]. ID2 dissociation is triggered by ATR/
ATM-mediated phosphorylation of a cluster of at least six
FANCI SQ motifs, and is followed by the monoubiquitination of
FANCD2 [38,39]. Once monoubiquitinated, FANCD2 can then
facilitate that recruitment of several structure specific
nucleases, including FAN1 and FANCP/SLX4, initiating the
process of ICL removal [40-46].
Materials and Methods
Cell culture
COS-7, HeLa, and IMR90 cells were grown in Dulbecco's
modified Eagle's medium (DMEM) supplemented with 12% v/v
FBS, L-glutamine and penicillin/streptomycin. 293FT viral
producer cells (Invitrogen) were cultured in DMEM containing
12% v/v FBS, 0.1 mM non-essential amino acids, 1 mM sodium
pyruvate, L-glutamine, and penicillin/streptomycin. PD20 FA-
D2 (FANCD2hy/-) cells were purchased from Coriell Cell
Repositories (Catalog ID GM16633). These cells harbor a
maternally inherited A-G change at nucleotide 376 that leads to
the production of a severely truncated protein, and a paternally
inherited missense hypomorphic (hy) mutation leading to a
R1236H change [14]. To generate stable lines expressing wild
type or mutant FANCD2, FA-D2 cells were infected with
pLenti6.2-FANCD2 (Invitrogen) lentivirus, followed by selection
in DMEM supplemented with 12% v/v FBS, L-glutamine,
penicillin/streptomycin and 2 μg/ml blasticidin. KEAE FA-D2
cells and KEAE FA-D2 + FANCD2 cells were a kind gift from
Detlev Schindler of the University of Würzburg [15]. These cells
were telomerase immortalized using pBABE-hTERT and grown
in DMEM supplemented with 12% v/v FBS, L-glutamine,
penicillin/streptomycin and 0.75 μg/ml puromycin.
Antibodies and immunoblotting
For immunoblotting analysis, cell pellets were washed in
PBS and lysed in 2% w/v SDS, 50 mM Tris-HCl, 10 mM EDTA.
Proteins were resolved on NuPage 3-8% w/v Tris-Acetate or
4-12% w/v Bis-Tris gels (Invitrogen) and transferred to
polyvinylidene difluoride (PVDF) membranes. The following
antibodies were used: rabbit polyclonal antisera against
FANCD2 (NB100-182; Novus Biologicals), FANCI (Dr. Patrick
Sung, Yale University), H2A (07-146; Millipore), and mouse
monoclonal sera against α-tubulin (MS-581-PO; Neomarkers),
GFP (sc-9996; Santa Cruz), and V5 (R96025; Invitrogen).
Immunofluorescence microscopy
For immunofluorescence microscopy (IF) analysis, cells were
seeded in 4-well tissue culture slides (BD Falcon) and treated
with mitomycin C (MMC) for 18 h. Soluble cellular proteins
were pre-permeabilized with 0.3% v/v Triton X-100 and cells
were fixed in 4% w/v paraformaldehyde and 2% w/v sucrose at
4°C followed by permeabilization in 0.3% v/v Triton X-100 in
PBS. Fixed cells were blocked for 30 minutes in antibody
dilution buffer (5% v/v goat serum, 0.1% v/v NP-40, in PBS)
and incubated with primary antibody for 1 h. Cells were washed
three times in PBS, as well as permeabilization buffer, and
incubated for 30 min at room temperature with an Alexa Fluor
488-conjugated secondary antibody combined with Texas Red
labeled phalloidin. The slides were counterstained and
mounted in vectashield plus 4’6-diamidine-2-phenylindole
dihydrochloride (DAPI) (Vector Laboratories). Nuclear foci were
analyzed using a Zeiss AxioImager.A1 upright epifluorescent
microscope with AxioVision LE 4.6 image acquisition software.
Primary antibodies used for IF were anti-FANCD2 (NB100-182;
Novus Biologicals), anti-FANCI (A300-212A; Bethyl
Laboratories), anti-DNA-PKCS pS2056 (ab18192; Abcam), and
anti-V5 (R960-25; Invitrogen).
Plasmids, site-directed mutagenesis, and transient
transfections
The full length, ΔN57, and ΔN100 FANCD2 cDNA
sequences were TOPO cloned into the pENTR⁄D-TOPO
(Invitrogen) entry vector, and subsequently recombined into the
pLenti6.2/V5-DEST (Invitrogen) destination vector and used to
generate lentivirus for the generation of stable cell lines. The
FANCD2-KRR4NNN (FANCD2-3N) cDNA was generated by
site-directed mutagenesis of the wild type FANCD2 cDNA
using the Quikchange Site-directed Mutagenesis Kit
(Stratagene). The forward and reverse oligonucleotide
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sequences used are as follows: FP, 5’-
TTCACCATGGTTTCCAACAACAACCTGTCAAAATCTGAGG-
3’; RP, 5’-
CCTCAGATTTTGACAGGTTGTTGTTGGAAACCATGGTGAA
-3’. The FANCD2 GFP fusion vectors D2-1-27-GFP, D2-24-55-
GFP, and D2-1-58-GFP were generated by PCR amplifying the
coding sequences of amino acids 1-27, 24-55, or 1-58 of
FANCD2 and directionally cloning these fragments into the
multiple cloning site of pEGFP-N1 (Clontech) (see Methods
S1). The FANCI-GFP construct was a gift from Tony Huang in
the Department of Biochemistry at New York University School
of Medicine. COS-7, HeLa, and IMR90 cells were transiently
transfected with plasmid DNA using Fugene 6 or X-
tremeGENE 9 (Roche) at a 1:3 ratio (μg DNA:μL Fugene 6) in
Opti-MEM. After incubating for 24 h, GFP fluorescence was
monitored using a Zeiss AxioImager X-Cite series 120Q
inverted fluorescence microscope with AxioVision LE 4.8 image
acquisition software. Ivermectin (Sigma) was added to a final
concentration of 25 μM 4 h following transfection.
Cellular fractionation
Soluble proteins were removed by extraction in cytoskeletal
buffer (CSK) (10 mM PIPES pH 6.8, 300 mM sucrose, 100 mM
NaCl, 3 mM MgCl2, 1 mM EGTA, and 0.5% v/v Triton-X-100)
for 10 minutes at 4°C. Pellets were washed once with CSK
buffer, lysed in SDS sample buffer (2% w/v SDS, 50 mM Tris-
HCl pH 7.4, 10 mM EDTA), boiled for 15 min, followed by
sonication for 10 s at 10% amplitude using a Fisher Scientific
Model 500 Ultrasonic Dismembrator.
Chromosome breakage analysis
Cells were incubated in the absence or presence of MMC for
18 h. Prior to harvesting, cells were treated with 0.1 ug/ml
Colcemid (Gibco/Invitrogen) for 2 h; pellets were then
incubated in 0.075 M KCl at 37°C for 18 min, followed by
fixation in Carnoy’s fixative (3:1 methanol:glacial acetic acid).
Cells were dropped onto chilled slides, air-dried, and then
stained with 2.5% w/v Giemsa solution (Sigma). Metaphases
were analyzed using a Zeiss AxioImager.A1 upright
epifluorescent microscope with Axio Vision LE 4.6 image
acquisition software.
Supporting Information
Figure S1.  FANCD2 contains a highly conserved amino-
terminal nuclear localization signal, which facilitates
nuclear expression of GFP. (A) cNLS mapper (http://nls-
mapper.iab.keio.ac.jp/cgi-bin/NLS_Mapper_form.cgi) was used
to analyze the FANCD2 amino acid sequence for importin α/β-
dependent nuclear localization signals (NLSs), and identified
amino acids 2-58 as harboring several putative high scoring
bipartite NLSs (B). (C) A Clustal Omega (http://www.ebi.ac.uk/
Tools/msa/clustalo/) multiple sequence alignment of full length
FANCD2 corresponding to Figure 1A. Hs, Homo sapiens; Pt,
Pan troglodytes; Mm, Mus musculus; Cf, Canine familiaris; Gg,
Gallus gallus; Xt, Xenopus tropicalis; Dr, Danio rerio. (D)
D2-1-58-GFP localizes primarily to the nucleus. IMR90 cells
were transiently transfected with the indicated GFP constructs
and analyzed by inverted fluorescence microscopy. (E and F)
HeLa cells were transiently transfected with wild type GFP
(GFP-WT) or GFP fused to amino acids 1-58 of FANCD2 (D2-
NLS-GFP), incubated in the absence or presence of 25 μM
ivermectin for 20 h, followed by analysis by inverted
fluorescence microscopy. (F) The % of cells exhibiting both
cytoplasmic and nuclear (Cyto. + Nucl.) and exclusive nuclear
(Nuclear) staining were scored and plotted. Error bars
represent the standard errors of the means from two
independent experiments. ***, p < 0.001. (G and H) HeLa cells
were transiently transfected with the indicated GFP constructs
and 24 h later cell pellets were fractionated into soluble (S) and
chromatin (C) fractions. Fractions were resolved by SDS-PAGE
and immunoblotted with antibodies to GFP, α-tubulin, and H2A.
W, unfractionated whole-cell extract. (H) The integrated
densities of the protein bands from Figure S1G were quantified
using ImageJ image processing and analysis software, and
plotted. While the integrated band densities for a single
experiment are shown, these experiments were repeated
several times with very similar findings. WCE, whole-cell
extract.
(PDF)
Figure S2.  The FANCD2 NLS is required for the nuclear
localization of a subset of FANCI. (A) KEAE FA-D2 hTERT
cells or KEAE FA-D2 hTERT cells stably expressing FANCD2-
WT were incubated in the absence (NT) or presence of MMC
for 24 h, fixed, stained with rabbit polyclonal anti-FANCD2 or
anti-FANCI antibody and counterstained with phalloidin and
DAPI. AF-488, Alexa Fluor 488. (B) FA-D2 cells stably
expressing FANCD2-WT, FANCD2-∆N57, or FANCD2-∆N100
were incubated in the absence (NT) or presence of MMC for 24
h, fixed, stained with mouse monoclonal anti-V5 (red) to detect
V5-tagged FANCD2 and rabbit polyclonal anti-FANCI (green)
and counterstained with DAPI (blue). IF microscopy was
performed with (+ Pre-Perm) and without (No Pre-Perm) a pre-
permeabilization step (see Materials and Methods). The pre-
permeabilization step leads to complete loss of fluorescent
signal for FANCD2-ΔN57 and FANCD2-ΔN100 because of the
high solubility of these proteins (see Figure 2B), while this step
is necessary for the resolution of FANCI fluorescence signal.
(PDF)
Figure S3.  The FANCD2 NLS is required for efficient
FANCI chromatin association. FA-D2 cells stably expressing
FANCD2-WT (WT), FANCD2-∆N57 (∆N57), FANCD2-∆N100
(∆N100) or FANCD2-3N (3N) were incubated in the absence or
presence of MMC for 18 h and cell pellets were fractionated
into soluble and chromatin-associated fractions (see Figures
4B and C). The total integrated densities of the chromatin-
associated (C) nonubiquitinated and monoubiquitinated FANCI
protein bands were quantified using ImageJ image processing
and analysis software, and plotted. While the integrated band
densities for a single experiment are shown, these experiments
were repeated several times with similar findings. NT, not
treated; MMC, MMC-treated.
(TIF)
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Figure S4.  The FANCD2 NLS deletion mutants fail to
rescue the MMC sensitivity of FA-D2 cells. FA-D2 cells
stably expressing FANCD2-WT, FANCD2-K561R, FANCD2-
∆N57, FANCD2-∆N100, or FANCD2-3N were treated with the
indicated concentrations of MMC for 7-10 days. Cells were
fixed and stained with crystal violet and percent survival
calculated and plotted. Each measurement was performed in
triplicate and experiments were performed multiple times with
similar results. The 20% trimmed means (20%) for all recorded
measurements were calculated and plotted. Error bars
represent the standard errors of the means.
(TIF)
Table S1.  Detection of importin subunit β1, NUP160 and
NUP155 in FANCD2 immune complexes. FANCD2 immune
complexes were analyzed using a LTQ Orbitrap Velos hybrid
mass spectrometer.
(TIF)
Methods S1.  (DOCX)
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